Suchergebnisse - "Barlow, William E"

PubPharm (12)

1

Dietary Supplement Use During Chemotherapy and Survival Outcomes of Patients With Breast Cancer Enrolled in a Cooperative Group Clinical Trial (SWOG S0221)

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2020

von Ambrosone, C. | Zirpoli, G. | Hutson, A. | +17

CommentIn: J Clin Oncol. 2020 Jun 20;38(18):2111. - PMID 32315274

2

Validation of the DNA Damage Immune Response Signature in Patients With Triple-Negative Breast Cancer From the SWOG 9313c Trial

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2019

von Sharma, P. | Barlow, W. | Godwin, A. | +19

3

SWOG S0221 : a phase III trial comparing chemotherapy schedules in high-risk early-stage breast cancer

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2015

von Budd, G. | Barlow, W. | Moore, H. | +17

4

Phase III comparison of standard doxorubicin and cyclophosphamide versus weekly doxorubicin and daily oral cyclophosphamide plus granulocyte colony-stimulating factor as neoadjuvant therapy for inflammatory and locally advanced breast cancer : SWOG 0012

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2011

von Ellis, G. | Barlow, W. | Gralow, J. | +6

5

Manganese superoxide dismutase polymorphism, treatment-related toxicity and disease-free survival in SWOG 8897 clinical trial for breast cancer

enthalten in: Breast cancer research and treatment | 2010

von Yao, S. | Barlow, W. | Albain, K. | +15

6

Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy : a retrospective analysis of a randomised trial

enthalten in: The Lancet. Oncology | 2010

von Albain, K. | Barlow, W. | Shak, S. | +20

CommentIn: Lancet Oncol. 2010 Jan;11(1):6-7. - PMID 20005177

7

Adjuvant chemotherapy and timing of tamoxifen in postmenopausal patients with endocrine-responsive, node-positive breast cancer : a phase 3, open-label, randomised controlled trial

enthalten in: Lancet (London, England) | 2009

von Albain, K. | Barlow, W. | Ravdin, P. | +18

CommentIn: Lancet. 2009 Dec 19;374(9707):2029-2030. - PMID 20004965

8

Myeloperoxidase genotypes and enhanced efficacy of chemotherapy for early-stage breast cancer in SWOG-8897

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2009

von Ambrosone, C. | Barlow, W. | Reynolds, W. | +13

9

Outcome of patients with early-stage breast cancer treated with doxorubicin-based adjuvant chemotherapy as a function of HER2 and TOP2A status

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2009

von Tubbs, R. | Barlow, W. | Budd, G. | +11

CommentIn: J Clin Oncol. 2009 Aug 20;27(24):3875-6. - PMID 19620479

10

Nitric oxide synthase variants and disease-free survival among treated and untreated breast cancer patients in a Southwest Oncology Group clinical trial

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2009

von Choi, J. | Barlow, W. | Albain, K. | +14